Sex: F
Vaccine: COVID19
Symptoms: Vaccination site mass, Vaccination site pain, Vaccination site pruritus, Vaccination site swelling, Vaccination site warmth
Clinical narrative: Dose number 3; Redness and slight itching sensation / at the injection site; Redness and slight itching sensation / at the injection site; mild fever; sore throat; injection sight became very sensitive to the touch, a slight bump of the spot would hurt; injection sight became very sensitive to the touch, a slight bump of the spot would hurt; injection sight became very sensitive to the touch, a slight bump of the spot would hurt; the spot was hotter to the touch; has been roughly 4 days of it being itchy bed and swollen; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 22 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left (Lot number: 33030BD) as dose 3 (booster), single for covid-19 immunisation. Relevant medical history included: "Allergies: some types of bandage adhesive" (unspecified if ongoing), notes: Known allergies: some types of bandage adhesive. The patient took concomitant medications. Vaccination history included: Bnt162b2 (Dose Number: 2, Location of injection: Arm Left), administration date: 26Apr2021, when the patient was 21 years old, for Covid-19 immunization; Bnt162b2 (Dose Number: 1, Location of injection: Arm Left), administration date: 05Apr2021, when the patient was 21 years old, for Covid-19 immunization. The following information was reported: IMMUNISATION (non-serious), outcome "unknown", described as "Dose number 3"; VACCINATION SITE ERYTHEMA (non-serious), VACCINATION SITE PRURITUS (non-serious) all with onset 04Dec2021, outcome "not recovered" and all described as "Redness and slight itching sensation / at the injection site"; PYREXIA (non-serious) with onset 04Dec2021, outcome "not recovered", described as "mild fever"; OROPHARYNGEAL PAIN (non-serious) with onset 04Dec2021, outcome "not recovered", described as "sore throat"; VACCINATION SITE HYPERSENSITIVITY (non-serious), VACCINATION SITE MASS (non-serious), VACCINATION SITE PAIN (non-serious) all with onset 04Dec2021, outcome "not recovered" and all described as "injection sight became very sensitive to the touch, a slight bump of the spot would hurt"; VACCINATION SITE WARMTH (non-serious) with onset 04Dec2021, outcome "not recovered", described as "the spot was hotter to the touch"; VACCINATION SITE SWELLING (non-serious) with onset 04Dec2021, outcome "not recovered", described as "has been roughly 4 days of it being itchy bed and swollen". Therapeutic measures were not taken as a result of vaccination site erythema, vaccination site pruritus, pyrexia, oropharyngeal pain, vaccination site hypersensitivity, vaccination site mass, vaccination site pain, vaccination site warmth, vaccination site swelling. No follow-up attempts are possible. No further information is expected.  Additional information: The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19.